Experiences with
Evolocumab9 public posts
Want to take advantage of all our features? Just log in!
or
'Huge advance' in fighting world's biggest killer
The new drug - evolocumab - changes the way the liver works to also cut bad cholesterol.
"It is much more effective than statins," said Prof Peter Sever, from Imperial College London.
He organised the bit of the trial taking place in the UK with funding from the drug company Amgen.